STAT6 PROTAC degrader

STAT6 PROTAC degraders are a class of targeted protein degradation (TPD) therapeutics designed to selectively bind and degrade Signal Transducer and Activator of Transcription 6 (STAT6). STAT6 is a key transcription factor downstream of the interleukin-4 (IL-4) and interleukin-13 (IL-13) receptors, serving as a central driver of T helper type 2 (Th2) cell-mediated inflammation in allergic and autoimmune diseases such as atopic dermatitis and asthma, as well as certain cancers. By utilizing proteolysis-targeting chimera (PROTAC) technology, these bifunctional molecules recruit an E3 ubiquitin ligase (such as cereblon or VHL) to STAT6, leading to its polyubiquitination and subsequent degradation by the 26S proteasome. This approach offers a potential therapeutic advantage over traditional monoclonal antibodies by completely clearing the intracellular signaling machinery rather than temporarily blocking extracellular ligands.

Other names

STAT6 PROTACSTAT-6 PROTACSTAT 6 PROTACSTAT6 degraderSTAT-6 degraderSTAT 6 degraderSTAT6 proteolysis-targeting chimeraSTAT-6 proteolysis-targeting chimeraSTAT 6 proteolysis-targeting chimera